Literature DB >> 29543630

μ-Opioid Receptor Agonists: Do They Have Utility in the Treatment of Acute Pain?

Thomas K Henthorn1, Susan K Mikulich-Gilbertson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29543630      PMCID： PMC5903950          DOI： 10.1097/ALN.0000000000002177

Source DB:  PubMed          Journal:  Anesthesiology        ISSN： 0003-3022            Impact factor:   7.892


× No keyword cloud information.
  16 in total

Review 1.  Multimodal analgesia as an alternative to the risks of opioid monotherapy in surgical pain management.

Authors:  John J Savarese; Norman G Tabler
Journal:  J Healthc Risk Manag       Date:  2017-07

Review 2.  The utility function of antihypertensive therapy.

Authors:  L B Sheiner; K L Melmon
Journal:  Ann N Y Acad Sci       Date:  1978-03-30       Impact factor: 5.691

3.  Doxapram-mediated Increase in Cardiac Output Reduces Opioid Plasma Concentrations: A Pharmacokinetic/Pharmacodynamic-Pharmacokinetic/Pharmacodynamic Modeling Study in Healthy Volunteers.

Authors:  M Roozekrans; E Olofsen; R van der Schrier; M Boom; R Mooren; A Dahan
Journal:  Clin Pharmacol Ther       Date:  2017-03-25       Impact factor: 6.875

4.  Pharmacokinetics of ximelagatran and relationship to clinical response in acute deep vein thrombosis.

Authors:  Marie Cullberg; Ulf G Eriksson; Karin Wåhlander; Henry Eriksson; Sam Schulman; Mats O Karlsson
Journal:  Clin Pharmacol Ther       Date:  2005-04       Impact factor: 6.875

5.  Alfentanil and placebo analgesia: no sex differences detected in models of experimental pain.

Authors:  Erik Olofsen; Raymonda Romberg; Hans Bijl; René Mooren; Frank Engbers; Benjamin Kest; Albert Dahan
Journal:  Anesthesiology       Date:  2005-07       Impact factor: 7.892

6.  Reducing the Risks of Relief--The CDC Opioid-Prescribing Guideline.

Authors:  Thomas R Frieden; Debra Houry
Journal:  N Engl J Med       Date:  2016-03-15       Impact factor: 91.245

7.  Pharmacokinetic-pharmacodynamic modeling of the effectiveness and safety of buprenorphine and fentanyl in rats.

Authors:  Ashraf Yassen; Erik Olofsen; Jingmin Kan; Albert Dahan; Meindert Danhof
Journal:  Pharm Res       Date:  2007-10-04       Impact factor: 4.200

8.  Fentanyl utility function: a risk-benefit composite of pain relief and breathing responses.

Authors:  Merel Boom; Erik Olofsen; Meike Neukirchen; René Fussen; Justin Hay; Geert Jan Groeneveld; Leon Aarts; Elise Sarton; Albert Dahan
Journal:  Anesthesiology       Date:  2013-09       Impact factor: 7.892

9.  Evaluation of methods for estimating population pharmacokinetics parameters. I. Michaelis-Menten model: routine clinical pharmacokinetic data.

Authors:  L B Sheiner; S L Beal
Journal:  J Pharmacokinet Biopharm       Date:  1980-12

Review 10.  Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis.

Authors:  Kevin E Vowles; Mindy L McEntee; Peter Siyahhan Julnes; Tessa Frohe; John P Ney; David N van der Goes
Journal:  Pain       Date:  2015-04       Impact factor: 6.961
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.